
TJX earnings beat, Revenue misses in Q2
Investing.com - TJX (NYSE:TJX) reported on Wednesday second quarter {{erl-8227||earnings that beat analysts' forecasts and revenue that fell short of expectations. TJX announced earnings...
Investing.com - TJX (NYSE:TJX) reported on Wednesday second quarter {{erl-8227||earnings that beat analysts' forecasts and revenue that fell short of expectations. TJX announced earnings...
By Malvika Gurung Investing.com -- Cipla (NS:CIPL): Ashish Adukia has been appointed as the global CFO and key managerial personnel of the pharmaceutical giant, while Dinesh Jain’s...
Stocks in news: HDFC Asset Management Company, Ansal Housing, Bajaj Hindusthan, Cipla, Bajaj Electricals, Future Lifestyle Fashions and more
Stocks to Watch: ICICI Securities, Axis Capital and Citigroup Global Markets are among the 5 investment bankers selected to manage the sale of the government's 29.53% residual stake in...
Stocks to watch today: Shares of firms like NTPC, Cipla, SAIL, Tata Chemicals, and others will be in focus in Friday's trade
State-owned power giant NTPC floated a tender to raise Rs 5,000 crore term loan from financial institutions. As per the document, the bids can be submitted till 1100 hours on August...
Stocks to Watch: Check out the companies making headlines before the opening bell.
The Indian finance minister suggested against using cryptocurrency.The law enforcement organization blocked the assets of two crypto exchanges.At a BJP Economic Cell event on Saturday,...
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 82542.57 Crore) operating in Pharmaceuticals sector.
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 81586.39 Crore) operating in Pharmaceuticals sector.
Cipla is on track to launch key products, such as gAdvair, gAbraxane, gRevlimid and three peptide products over FY23-24, it said, adding that the US sales run-rate will improve from H2FY23,...
Stocks to Watch today: ITC, UPL, Zomato, Arvind, Bajaj Consumer Care, among others will release their Q1 earnings today.
By Malvika Gurung Investing.com -- A slew of companies is lined up to conduct different corporate actions on Friday, including June quarterly earnings announcements and board meetings, among...
Cipla Q1 results preview: Analysts attribute the likely dull performance due to the high base of last year, and the reduction in revenue contribution from Covid-19 therapies in the recent...
Powered by Capital Market - Live News
By Malvika Gurung Investing.com -- The country’s most valued company by market capitalization Reliance Industries (NS:RELI) posted a double-digit bottomline growth, along with the best...
Though value added projects are being undertaken, companies need to step up R&D spends as innovation is the only way to fight pricing pressures
By Malvika Gurung Investing.com -- Cipla (NS:CIPL): Subsidiary Cipla Health has signed agreements for the acquisition of nutritional supplement brand Endura Mass from Medinnbelle...
The drug major said its wholly-owned subsidiary, Cipla Health, has signed definitive agreements for acquisition of Endura Mass from Medinnbelle Herbalcare.
Indian equity markets are likely to open higher on Friday. SGX Nifty was up with gains signalling that Dalal Street is headed for a positive start, while global cues were mixed.
Stocks to watch today: Shares of firms like Tata Elxsi, ACC, Cipla, Adani Group Stocks, and others will be in focus in Friday's trade
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 75727.57 Crore) operating in Pharmaceuticals sector.
Cipla Ltd., incorporated in the year 1935, is a Large Cap company (having a market cap of Rs 75457.28 Crore) operating in Pharmaceuticals sector.
Investing.com – India equities were higher at the close on Thursday, as gains in the Metals, Consumer Durables and Real Estate sectors propelled shares higher. At the close in NSE, the...
Constant price erosion in the US markets means that volumes and new products are necessary to act as levers for growth
The US Food and Drug Administration (USFDA) conducted a pre-approval inspection (PAI) at the drug major's Indore plant from 27 June 2022 to 1 July 2022.
Following a Pre-Approval Inspection
Stocks in news: Kotak Mahindra Bank, TCS, Vedanta, Tata Power, Cipla and more
Investing.com – India equities were lower at the close on Thursday, as losses in the Metals, Auto and Real Estate sectors propelled shares lower. At the close in NSE, the Nifty 50 fell...
By Malvika Gurung Investing.com -- Reliance Industries (NS:RELI): The telecom-to-retail conglomerate’s electric commercial vehicle maker Altigreen inaugurated its EV service centre in...
By Malvika Gurung Investing.com -- State Bank of India (NS:BOI): The public lender’s board has approved raising up to $2 billion or Rs 15,430 crore in the ongoing fiscal from overseas...
By Malvika Gurung Investing.com -- HCL Tech: The IT giant’s subsidiary will acquire the Bengaluru-based aftermarket digital transformation company Quest Informatics, in an all-cash deal for...
By Malvika Gurung Investing.com -- Foreign investors have continued their selling spree in the quarter ending March 2022, offloading Indian shares worth over Rs 1.1 lakh crore, while selling...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.